420 related articles for article (PubMed ID: 15655814)
41. Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment.
Sun LC; Chu KS; Cheng SC; Lu CY; Kuo CH; Hsieh JS; Shih YL; Chang SJ; Wang JY
BMC Cancer; 2009 Aug; 9():288. PubMed ID: 19691850
[TBL] [Abstract][Full Text] [Related]
42. Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancer.
Carpelan-Holmström M; Haglund C; Lundin J; Järvinen H; Roberts P
Eur J Cancer; 1996 Jun; 32A(7):1156-61. PubMed ID: 8758246
[TBL] [Abstract][Full Text] [Related]
43. Tumor-associated glycoprotein-72 serum levels complement carcinoembryonic antigen levels in monitoring patients with gastrointestinal carcinoma. A longitudinal study.
Guadagni F; Roselli M; Amato T; Cosimelli M; Mannella E; Perri P; Abbolito MR; Cavaliere R; Colcher D; Greiner JW
Cancer; 1991 Dec; 68(11):2443-50. PubMed ID: 1933781
[TBL] [Abstract][Full Text] [Related]
44. Carcinoembryonic antigen as a marker of radioresistance in colorectal cancer: a potential role of macrophages.
Huang EY; Chang JC; Chen HH; Hsu CY; Hsu HC; Wu KL
BMC Cancer; 2018 Mar; 18(1):321. PubMed ID: 29580202
[TBL] [Abstract][Full Text] [Related]
45. Carcinoembryonic antigen and matrix metalloproteinase 2 serum and peritoneal washes concentration in staging and prognosis in colorectal cancer patients.
Guzel T; Mirowska-Guzel D; Lech G; Wroński M; Iwanowska M; Słodkowski M
Pol Przegl Chir; 2018 Jun; 90(5):36-43. PubMed ID: 30426942
[TBL] [Abstract][Full Text] [Related]
46. Immunohistochemical analysis of resected clinical stage I pulmonary adenocarcinomas with high preoperative levels of serum carcinoembryonic antigen.
Sawabata N; Hirano H; Inoue M; Okumura Y; Asada H; Takeda S; Maeda H
Ann Thorac Surg; 2003 Jul; 76(1):203-7. PubMed ID: 12842541
[TBL] [Abstract][Full Text] [Related]
47. Cytokeratin serum biomarkers in patients with colorectal cancer.
Holdenrieder S; Stieber P; Liska V; Treska V; Topolcan O; Dreslerova J; Matejka VM; Finek J; Holubec L
Anticancer Res; 2012 May; 32(5):1971-6. PubMed ID: 22593474
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of predictive markers for patients with advanced colorectal cancer.
Byström P; Berglund Å; Nygren P; Wernroth L; Johansson B; Larsson A; Glimelius B
Acta Oncol; 2012 Sep; 51(7):849-59. PubMed ID: 22974092
[TBL] [Abstract][Full Text] [Related]
49. Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery.
Yang KL; Yang SH; Liang WY; Kuo YJ; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC; Chu LS; Wang LW
Radiat Oncol; 2013 Mar; 8():43. PubMed ID: 23452434
[TBL] [Abstract][Full Text] [Related]
50. CEA and CA 19-9 are still valuable markers for the prognosis of colorectal and gastric cancer patients.
Sisik A; Kaya M; Bas G; Basak F; Alimoglu O
Asian Pac J Cancer Prev; 2013; 14(7):4289-94. PubMed ID: 23991991
[TBL] [Abstract][Full Text] [Related]
51. Outcome of colorectal carcinoma in patients under 40 years of age.
Lin JT; Wang WS; Yen CC; Liu JH; Yang MH; Chao TC; Chen PM; Chiou TJ
J Gastroenterol Hepatol; 2005 Jun; 20(6):900-5. PubMed ID: 15946138
[TBL] [Abstract][Full Text] [Related]
52. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins.
Cutait R; Alves VA; Lopes LC; Cutait DE; Borges JL; Singer J; da Silva JH; Goffi FS
Dis Colon Rectum; 1991 Oct; 34(10):917-20. PubMed ID: 1717210
[TBL] [Abstract][Full Text] [Related]
53. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568
[TBL] [Abstract][Full Text] [Related]
54. A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer.
Chang YT; Huang MY; Yeh YS; Huang CW; Tsai HL; Cheng TL; Wang JY
PLoS One; 2016; 11(10):e0163264. PubMed ID: 27701415
[TBL] [Abstract][Full Text] [Related]
55. Are high initial CEA and CA 19-9 levels associated with the presence of K-ras mutation in patients with metastatic colorectal cancer?
Selcukbiricik F; Bilici A; Tural D; Erdamar S; Soyluk O; Buyukunal E; Demirelli F; Serdengecti S
Tumour Biol; 2013 Aug; 34(4):2233-9. PubMed ID: 23625655
[TBL] [Abstract][Full Text] [Related]
56. [Usefulness of evaluation of carcinoembryonic antigen (CEA) and soluble fragments of cytokeratin 18-th (TPS) in postoperative monitoring of patients with colorectal cancer].
Sandelewski A; Kokocińska D; Partyka R; Kocot J; Starzewski J; Chanek I; Jałowiecki P
Pol Merkur Lekarski; 2005 Jun; 18(108):647-50. PubMed ID: 16124375
[TBL] [Abstract][Full Text] [Related]
57. Role of serum carcinoembryonic antigen in the detection of colorectal cancer before and after surgical resection.
Su BB; Shi H; Wan J
World J Gastroenterol; 2012 May; 18(17):2121-6. PubMed ID: 22563201
[TBL] [Abstract][Full Text] [Related]
58. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.
Toiyama Y; Miki C; Inoue Y; Okugawa Y; Tanaka K; Kusunoki M
Int J Cancer; 2009 Oct; 125(7):1657-62. PubMed ID: 19569242
[TBL] [Abstract][Full Text] [Related]
59. Preoperative carcinoembryonic antigen and prognosis of colorectal cancer. An independent prognostic factor still reliable.
Li Destri G; Rubino AS; Latino R; Giannone F; Lanteri R; Scilletta B; Di Cataldo A
Int Surg; 2015 Apr; 100(4):617-25. PubMed ID: 25875542
[TBL] [Abstract][Full Text] [Related]
60. Preoperative alkaline phosphatase elevation was associated with poor survival in colorectal cancer patients.
Hung HY; Chen JS; Chien-YuhYeh ; Tang R; Hsieh PS; Wen-SyTasi ; You YT; You JF; Chiang JM
Int J Colorectal Dis; 2017 Dec; 32(12):1775-1778. PubMed ID: 29030683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]